Delivery Order SPE2DB24D2100-SPE2DB24FBBQB
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The $10,024.40 firm fixed price delivery order is for the supply of Remicade 100 mg vials, a pharmaceutical product. The contract has an ultimate completion date of July 11, 2025 and is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract...
- This federal contract award is for the procurement of REMICADE 100 MG VIALS by the Defense Logistics Agency (DLA) from AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $10,121.10 firm fixed-price delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company AmerisourceBergen Corporation. The $22,303.54 firm fixed price delivery order is for the provision of 100 mg vials of the pharmaceutical product Remicade. The award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as the primary vehicle for AmerisourceBergen Drug Corp to deliver pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $7,279.02 Firm Fixed Price Delivery Order contract is for the supply of REMICADE 100 MG VIALS, a prescription medication, with a completion date of April 18, 2024. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a single-award Indefinite...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 100 mg REMICADE vials, a specialty medication, with a ceiling value of $2,735.08 and a period of performance through June 10, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,102.52, is for the delivery of REMICADE 100 MG VIALS, a specialty medication. The contract has a firm fixed price pricing type and an ultimate completion date of March 16, 2023. This award is a part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
- This contract award, with ID SPE2DX15D1053|SPE2DX24F6NRR, is for the supply of REMICADE 100 MG VIALS to the Defense Logistics Agency (DLA) Troop Support Medical. The $8,198.46 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of June 13, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the...
- This federal contract award, valued at $12,745.09, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is for the delivery of Remicade 100 mg vials, a pharmaceutical product, with a completion date of April 18, 2024. This is a delivery order contract with a firm fixed price pricing type. The award is not associated with any set-aside...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award is a firm fixed price delivery order for the pharmaceutical product Remicade 100 mg vials, with a ceiling value of $10,275.20 and a performance period through April 4, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,676.80 to AmerisourceBergen Drug Corp for the supply of Remicade 100 mg vials, with an ultimate completion date of December 18, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical distributor and...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB24FBBQBDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,058.97 firm-fixed-price delivery order is for the supply of REMICADE 100 mg vials, a specialty medication. The contract has an ultimate completion date of May 23, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.1k | 5/22/24 |